Article
How a Mutation that Slows Aging Can Also Disproportionately Extend End-of-Life Decrepitude.
Cell reports - 18 Apr 2017
Podshivalova Katie, Kerr Rex A, Kenyon Cynthia
Abstract excerpt
The goal of aging research is to extend healthy, active life. For decades, C. elegans daf-2 insulin/insulin-like growth factor 1 (IGF-1) receptor mutants have served as a model for extended lifespan and youthfulness. However, a recent report suggested that their longevity is associated with an undesirable phenotype: a disproportionately long period of decrepitude at the end of life. In the human population, such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
